Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011

Diabetes Research and Clinical Practice

Volumn 103, Issue 2, 2014, Pages 319-327

  Esteghamati, Alireza ^a   Etemad, Koorosh ^b   Koohpayehzadeh, Jalil ^b   Abbasi, Mehrshad ^a   Meysamie, Alipasha ^a   Noshad, Sina ^a   Asgari, Fereshteh ^b   Mousavizadeh, Mostafa ^a   Rafei, Ali ^b   Khajeh, Elias ^a   Neishaboury, Mohamadreza ^a   Sheikhbahaei, Sara ^a   Nakhjavani, Manouchehr ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Diabetes mellitus; Impaired fasting glucose; Obesity; Population attributable fraction; Surveillance of Risk Factors of Non communicable Diseases; Trends

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AWARENESS; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IRAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; TREND STUDY; URBAN POPULATION; WAIST CIRCUMFERENCE; ANALYSIS; BLOOD; DIET RESTRICTION; EPIDEMIOLOGY; MIDDLE AGED; PREVALENCE;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; OBESITY; PREVALENCE; WAIST CIRCUMFERENCE;

EID: 84895806978     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.12.034     Document Type: Article

References (41)

1. International Diabetes Federation IDF diabetes atlas 2011, International Diabetes Federation, Brussels.
2. Guariguata L. By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012. Diabetes Res Clin Pract 2012, 98:524-525.
3. Esteghamati A., Meysamie A., Khalilzadeh O., Rashidi A., Haghazali M., Asgari F., et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health 2009, 9:167.
4. Wang Y., Mi J., Shan X.Y., Wang Q.J., Ge K.Y. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes 2007, 31:177-188.
5. Gonzalez E.L., Johansson S., Wallander M.A., Rodriguez L.A. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009, 63:332-336.
6. Lipscombe L.L., Hux J.E. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007, 369:750-756.
7. American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596-615.
8. Esteghamati A., Khalilzadeh O., Anvari M., Meysamie A., Abbasi M., Forouzanfar M., et al. The economic costs of diabetes: a population-based study in Tehran, Iran. Diabetologia 2009, 52:1520-1527.
9. Shaw J., Sicree R., Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
10. Nichols G.A., Brown J.B. Higher medical care costs accompany impaired fasting glucose. Diabetes Care 2005, 28:2223-2229.
11. Nathan D.M., Davidson M.B., DeFronzo R.A., Heine R.J., Henry R.R., Pratley R., et al. Impaired fasting glucose and impaired glucose tolerance implications for care. Diabetes Care 2007, 30:753-759.
12. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007, 356:213-215.
13. Esteghamati A., Khalilzadeh O., Mohammad K., Meysamie A., Rashidi A., Kamgar M., et al. Secular trends of obesity in Iran between 1999 and 2007: national surveys of risk factors of non-communicable diseases. Metab Syndr Relat Disord 2010, 8:209-213.
14. Chan J.M., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994, 17:961-969.
15. Nagaya T., Yoshida H., Takahashi H., Kawai M. Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population. Diabet Med 2005, 22:1107-1111.
16. Esteghamati A., Gouya M.M., Abbasi M., Delavari A., Alikhani S., Alaedini F., et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 2008, 31:96-98.
17. Esteghamati A., Ashraf H., Rashidi A., Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract 2008, 82:104-107.
18. Statistical Centre of Iran Results of 2011 National Census by Age, Sex, Area of Residence, and Province 2014, www.amar.org.ir/Default.aspx?tabid=765.
19. Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., Byrd-Holt D.D., Li C., et al. Full accounting of diabetes and pre-diabetes in the US population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32:287-294.
20. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
21. Shera A.S., Jawad F., Maqsood A. Prevalence of diabetes in Pakistan. Diabetes Res Clin Pract 2007, 76:219-222.
22. Satman I., Yilmaz T., Sengul A., Salman S., Salman F., Uygur S., et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002, 25:1551-1556.
23. Ashraf H., Rashidi A., Noshad S., Khalilzadeh O., Esteghamati A. Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East. Expert Rev Cardiovasc Ther 2011, 9:309-320.
24. Chodick G., Heymann A.D., Shalev V., Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur J Epidemiol 2003, 18:1143-1146.
25. al-Mahroos F., McKeigue P.M. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 1998, 21:936-942.
26. Motlagh B., O'Donnell M., Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil 2009, 16:268-280.
27. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
28. Esteghamati A., Khalilzadeh O., Rashidi A., Kamgar M., Meysamie A., Abbasi M. Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007). J Phys Act Health 2011, 8:27-35.
29. Ghassemi H., Harrison G., Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr 2002, 5:149-155.
30. McBean A.M., Li S., Gilbertson D.T., Collins A.J. Differences in diabetes prevalence, incidence, and mortality among the elderly of four racial/ethnic groups: Whites, Blacks, Hispanics, and Asians. Diabetes Care 2004, 27:2317-2324.
31. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
32. King H., Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 1993, 16:157-177.
33. Ford E.S., Williamson D.F., Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997, 146:214-222.
34. Hu G., Lindstrom J., Valle T.T., Eriksson J.G., Jousilahti P., Silventoinen K., et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 2004, 164:892.
35. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
36. Narayan K.M.V., Boyle J.P., Thompson T.J., Gregg E.W., Williamson D.F. Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care 2007, 30:1562-1566.
37. Berg C., Rosengren A., Aires N., Lappas G., Torén K., Thelle D., et al. Trends in overweight and obesity from 1985 to 2002 in Göteborg, West Sweden. Int J Obes 2005, 29:916-924.
38. Hart C., Hole D., Lawlor D., Davey Smith G. How many cases of type 2 diabetes mellitus are due to being overweight in middle age? Evidence from the Midspan prospective cohort studies using mention of diabetes mellitus on hospital discharge or death records. Diabet Med 2007, 24:73-80.
39. Zandieh A., Esteghamati A., Morteza A., Noshad S., Khalilzadeh O., Gouya M.M., et al. Appropriate BMI cut-off values for identification of metabolic risk factors: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Ann Hum Biol 2012, 39:484-489.
40. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
41. American Diabetes Association Standards of medical care in diabetes - 2013. Diabetes Care 2013, 36(Suppl. 1):S11-S66.